I. Bailey-Healy

Effects of all-trans-retinoic acid in promoting alveolar repair.

C. Mao, P. Belloni, D. Leaffer, 2000, Chest.

Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity

Jean Y. Tang, J. Teng, I. Bailey-Healy, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.

Jean Y. Tang, K. Sarin, A. Oro, 2019, JAMA dermatology.

An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma.

A. Wysong, Jean Y. Tang, S. Aasi, 2014, Journal of the American Academy of Dermatology.

Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC).

Jean Y. Tang, S. Aasi, A. Chang, 2016, Journal of the American Academy of Dermatology.

Phase 2 Trial of a Neurokinin-1 Receptor Antagonist for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients: A Randomized Clinical Trial.

P. Kwon, M. Joing, Jean Y. Tang, 2020, Journal of the American Academy of Dermatology.

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.

P. Beachy, A. Colevas, Jynho Kim, 2016, JAMA dermatology.

Risk Factors for Basal Cell Carcinoma Among Patients With Basal Cell Nevus Syndrome: Development of a Basal Cell Nevus Syndrome Patient Registry

H. Chahal, Jean Y. Tang, Shufeng Li, 2017, JAMA dermatology.